Addyi (flibanserin)

About Sprout Pharmaceuticals

Sprout Pharmaceuticals is a pioneering commercial-stage biotech company that successfully challenged the status quo by developing and launching Addyi, the first FDA-approved pharmacologic treatment for low sexual desire in women. Founded and led by Cindy Eckert, the company built its case through extensive clinical trials involving over 13,000 participants, establishing a new scientific paradigm that women's desire is neurologically based. A decade post-approval, Sprout continues to champion women's health, focusing on expanding access, changing care paradigms, and rewriting the narrative around female sexual wellness. The company operates as a small, private, mission-driven team based in Raleigh, North Carolina.

Therapeutic Areas